Stock Market News

Pfizer ends global development of Beqvez gene therapy

Feb 20, 2025 - 21:00
 0
Pfizer ends global development of Beqvez gene therapy
Read More

Tags:

Previous Article

Repligen stock rises on positive Q4 results and 2025 outlook

Next Article

Your retirement savings are at risk in an openly insane stock market

Related Posts

US aviation sector calls for emergency funding for air traffic technology, staffing

US aviation sector calls for emergency funding for air ...

Feb 19, 2025  0

Intel antisemitism lawsuit dismissed

Intel antisemitism lawsuit dismissed

Feb 20, 2025  0

Asia stocks muted amid rate, tariff jitters; Alibaba fuels Hong Kong rally

Asia stocks muted amid rate, tariff jitters; Alibaba fu...

Feb 21, 2025  0